- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03112252
App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season
October 24, 2017 updated by: Prof. Dr. Ralph Mösges, University Hospital of Cologne
App-basierte Patientenbefragung Von Allergiepatienten Unter Medikation in Der Pollenflug-Saison Zur Bestimmung Der Auswirkung Einer Allergischen Rhinitis Auf Die Lebensqualität
App-based study of allergy patients under medication in the pollen season to determine the effect of allergic rhinitis on the quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The project aims to determine the effects of rhinitis on everyday life and thereby identify the affected pathways, irrespective of age, gender or gender socioeconomic status to lead a healthy and active life.
Study Type
Observational
Enrollment (Actual)
173
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
NRW
-
Cologne, NRW, Germany, 50931
- Institute of Medical Statistics, Informatics and Epidemiology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients with allergic rhinitis
Description
inclusion criteria patients with allergic rhinitis
exclusion criteria none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
allergic symptoms of patients
Time Frame: one month
|
allergic symptoms of patients during the pollen season
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ralph Mösges, Prof. Dr., University Hospital of Cologne
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 19, 2017
Primary Completion (Actual)
August 31, 2017
Study Completion (Actual)
August 31, 2017
Study Registration Dates
First Submitted
March 30, 2017
First Submitted That Met QC Criteria
April 12, 2017
First Posted (Actual)
April 13, 2017
Study Record Updates
Last Update Posted (Actual)
October 25, 2017
Last Update Submitted That Met QC Criteria
October 24, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IITMACVIA2017D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Allergic Rhinitis
-
Universitaire Ziekenhuizen KU LeuvenAZ Sint-Jan AVRecruitingPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis | Local Allergic RhinitisBelgium
-
Organon and CoCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
-
ALK-Abelló A/SCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
-
Humanis Saglık Anonim SirketiCompletedPerennial Allergic Rhinitis | Seasonal Allergic RhinitisIndia
-
Organon and CoCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
-
Organon and CoCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
-
West Penn Allegheny Health SystemPennsylvania Allergy and Asthma Research FoundationCompletedAllergy | Perennial Allergic Rhinitis | Seasonal Allergic RhinitisUnited States
-
Ahn-Gook Pharmaceuticals Co.,LtdSamsung Medical Center; Seoul St. Mary's Hospital; Seoul National University... and other collaboratorsCompletedAllergic Rhinitis | Perennial Allergic Rhinitis | Non-seasonal Allergic RhinitisKorea, Republic of
-
United Allergy ServicesCompletedPerennial Allergic Rhinitis With Seasonal VariationUnited States
Clinical Trials on no specifications. Depending on the patients
-
University of TartuNorth Estonian Medical CenterRecruiting
-
Ospedale Andrea Tortora di PaganiUnknown
-
Ospedale Andrea Tortora di PaganiUnknownCastration-resistant Prostate CancerItaly
-
Grupo Argentino de Tratamiento de la Leucemia AgudaRecruitingAcute Lymphoblastic Leukemia, AdultArgentina
-
University of ZurichCompleted
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, Puerto Rico, Thailand, Turkey
-
Alvotech Swiss AGActive, not recruitingChorioretinal Vascular DiseaseGeorgia
-
Centre Hospitalier Universitaire de NiceCentre Hospitalier d'Antibes Juans les Pins; Centre Hospitalier de CannesCompletedSchizophrenia | Autistic DisorderFrance
-
Marmara UniversitySaglik Bilimleri UniversitesiCompletedOral Health in Children With Inflammatory Bowel DiseaseTurkey
-
Swiss SOS Study GroupUniversitätsklinik für Neurochirurgie, Inselspital Bern; Département des Neurosciences... and other collaboratorsTerminatedStroke | Cognitive Impairment | Subarachnoid Hemorrhage | Delayed Cerebral Ischemia | Complication | Cognitive Deficit | Cognitive Deterioration | Cognitive Deficits Following Cerebral InfarctionSwitzerland